1. Hong Kong Stocks

  2. •

    Process industries

  3. •

    Textiles
Harbour Equine Holdings Limited

Harbour Equine Holdings Limited

HHKEX:8377
0.16
HKD
-0.01
(-7.39%)
65.46MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.48
0.42
0.56
0.37
0.26
0.18
0.2
0.19
0.17
0.16
0.05
- -
Basic EPS, GAAP
0.03
- -
-0.1
-0.06
-0.09
-0.06
-0.07
-0.06
-0.11
-0.09
-0.01
- -
Free Cash Flow per Basic Share
0.08
0.01
-0.13
-0.13
- -
-0.07
-0.05
-0.09
0.02
- -
-0.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.39
0.35
0.45
0.36
0.24
0.19
0.22
0.17
0.05
-0.04
-0.04
0.01
Tangible Book Value per Share
0.39
0.35
0.45
0.36
0.24
0.19
0.21
0.14
0.02
-0.05
-0.04
-0.02
Basic Weighted Avg Shares
174
174
133
174
222
251
367
409
409
409
429
409
Sales/Revenue/Turnover
83
73
74
65
59
45
73
76
69
67
22
- -
Operating Margin (%)
12.6
17.2
12.48
-16.67
-16.29
-19.52
-21.18
-27.21
-40.61
-26.79
-48.23
- -
Depreciation Expense
1
1
- -
1
3
3
4
4
3
1
1
- -
Net Income, GAAP
5
- -
-13
-11
-19
-16
-27
-23
-47
-37
-3
- -
Effective Tax Rate (%)
28.37
176.57
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
5.65
-0.66
-17.74
-16.83
-32.72
-34.67
-37.13
-30.03
-67.8
-55.18
-15.42
- -
Working Capital
50
50
65
40
28
35
58
30
-11
- -
1
-13
LT Debt
- -
- -
- -
- -
4
3
1
- -
1
23
20
- -
Total Equity
67
61
78
63
42
46
92
68
19
-15
-18
4
Return on Invested Capital (%)
- -
-8.52
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-2.4
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-0.74
-18.91
-15.38
-36.41
-35.41
-39.66
-28.69
-107.25
- -
- -
- -

Capital Structure

HKD

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
ST Debt
- -
34
27
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
409
409
409
Market Capitalization
76
74
65

Working Capital

HKD

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
Total Current Assets
- -
48
39
Cash, Cash Equivalents & STI
- -
4
4
Accounts Receivable, Net
- -
8
8
Inventories
- -
15
7
Total Current Liabilities
- -
58
52
Payables & Accruals
- -
- -
- -
ST Debt
- -
34
27
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-18.22%
-31.2%
18.65%
Free Cash Flow
6,694.48%
10.59%
192.93%
Net Income, GAAP
264.68%
10.26%
-90.96%
Sales/Revenue/Turnover
-6.85%
-2.58%
-67.64%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
69
2024
- -
- -
67
2025
- -
- -
22

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.11
2024
- -
- -
-0.09
2025
- -
- -
-0.01

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Kwok Wai Wong
Full Time Employees
10
Sector
Process industries
Industry
Textiles
Address
Wah Kit Commercial Centre Hong Kong Hong Kong
IPO Date
Dec 15, 2017
Website
harbourequine.com
Similar Companies
Sasa Polyester Sanayi A.S. (BIST:SASA)
WF Holding Limited (NASDAQ:WFF)
Raymond Limited (NSE:RAYMOND)
Aksa Akrilik Kimya Sanayii A.S. (BIST:AKSA)
Filatex India Ltd (NSE:FILATEX)
Indo Count Industries Limited (NSE:ICIL)
Business
Harbour Equine Holdings Limited operates primarily in the equine care and wellness industry, specializing in the provision of horse-related health and nutrition products as well as equine healthcare services. The company’s core offerings include equine nutritional supplements; veterinary services and therapeutic treatments; horse racing and training support products; and equestrian equipment and accessories. It serves commercial horse racing entities, equestrian sports professionals, and horse owners predominantly across Hong Kong and the Asia-Pacific region. Founded in 2010 and headquartered in Hong Kong, Harbour Equine Holdings has developed a reputation for comprehensive equine wellness solutions that integrate both traditional and technologically advanced care methods. In terms of recent developments, Harbour Equine Holdings has undertaken strategic partnerships with leading veterinary research institutions to enhance its product portfolio and service efficacy. Within the last two years, the company launched innovative nutraceutical product lines designed to improve equine athletic performance and recovery. The company has also expanded its operational footprint by establishing new clinic facilities in mainland China to capture growing market demand. Furthermore, Harbour Equine Holdings completed a significant funding round in 2024 to support its expansion and product development initiatives, reinforcing its strategic focus on integrated equine health services and advanced nutritional products. Harbour Equine Holdings operates within the equine health and wellness industry segment, targeting professional equestrian athletes, racing stables, and individual horse owners seeking premier care solutions. The company’s geographic operations primarily span Hong Kong, mainland China, and broader Asia-Pacific markets. It is publicly listed under the ticker 8377.HK and continues to emphasize innovation and service quality in equine health maintenance and performance enhancement. This company description reflects Harbour Equine Holdings Limited’s specialized product and service offerings, recent strategic developments, and its position within the equine health industry, providing a comprehensive and factual overview suitable for financial databases.